Fact-checked by Grok 2 weeks ago

Farnesol

Farnesol is a naturally occurring , chemically known as (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol, with the molecular formula C₁₅H₂₆O and a molecular weight of 222.37 g/mol. It appears as a colorless to pale yellow liquid with a delicate floral odor, exhibiting a of approximately 283–285°C at 760 mmHg and a of 0.885 g/mL at 25°C. Insoluble in water but soluble in ethanol, ether, and oils, farnesol serves as a key intermediate in the for the biosynthesis of , steroids, and other isoprenoids in eukaryotes. In , farnesol is widely distributed as a and fungal metabolite, present in over 30 essential oils, including those from , , , and tuberose, where it can constitute up to 2.5% in sources like cabreuva wood oil. It functions as a quorum-sensing molecule in microorganisms, particularly in , where it inhibits hyphal formation, development, and drug efflux, thereby regulating and . In , farnesol acts as a precursor to juvenile hormones and serves as a , influencing reproductive behaviors and flagellar . Additionally, it exhibits antimicrobial properties and modulates calcium in vertebrates by inhibiting voltage-gated Ca²⁺ channels, potentially protecting against Ca²⁺-induced . Farnesol has diverse applications in and , primarily as a fragrance ingredient in perfumes and due to its pleasant , and as a agent in products. It also functions as an insect attractant and repellent in certain formulations. Emerging highlights its therapeutic potential, including anti-biofilm and effects when combined with drugs, as well as anti-cancer properties through induction of in cells via PI3K/Akt and MAPK pathways. Furthermore, farnesol shows promise in reducing and disease severity in models of and autoimmune conditions by influencing brain transcriptomics and pathways. Recent studies as of 2025 have demonstrated farnesol's efficacy in inhibiting glioma cell viability and induction, alleviating hepatic stress, and exerting anti-inflammatory effects in models.

Chemical Characteristics

Molecular Structure

Farnesol is an classified as an acyclic , with the molecular formula C₁₅H₂₆O and a of 222.37 g/mol. Its is (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol, reflecting its unsaturated structure featuring three double bonds and a group. This nomenclature highlights the 12-carbon main chain (dodeca) extended by methyl substituents, with triene indicating the positions of the double bonds at 2, 6, and 10. The molecular structure of farnesol is built from three units, each consisting of a five-carbon (2-methylbut-2-ene), linked head-to-tail to form a 15-carbon skeleton characteristic of sesquiterpenes. At one terminus, a hydroxyl group (-OH) is attached to carbon 1, making it a , while the chain features branch points with methyl groups at carbons 3, 7, and 11. These branches contribute to the branched, unsaturated nature of the molecule, which lacks any cyclic elements. The overall architecture can be visualized as a linear chain where the isoprene-derived segments create a repeating pattern of double bonds and methyl substitutions, essential for its chemical identity. The s in farnesol adopt predominantly the trans (E) configuration, specifically the (2E,6E)-trans-trans , which is the most common form encountered in natural and synthetic contexts. Farnesol is a constitutional of , sharing the same molecular formula but differing in the position of the hydroxyl group and one —nerolidol has the -OH at carbon 3 and a between carbons 1 and 2. This isomerism arises from alternative arrangements of the units during formation, yet both compounds retain the core alcohol framework.

Physical and Chemical Properties

Farnesol appears as a colorless to pale yellow liquid at , exhibiting a mild floral that contributes to its use in various formulations. This physical form is consistent across its common isomers, such as the trans,trans variant, under standard conditions. Key physical properties include a of 0.886 g/cm³ at 20°C, a of 283–284°C at 760 mmHg, and a of approximately 1.49 at 20°C. Farnesol demonstrates low , approximately 0.0065 g/L at 20°C, rendering it hydrophobic due to its nonpolar structure; it is miscible with organic solvents such as , , and oils. In terms of stability, farnesol is generally stable under ambient conditions but sensitive to oxidation upon prolonged to air, potentially forming aldehydes or ketones, and to light, which may accelerate degradation; it is recommended to store it in cool, dark conditions to maintain integrity. It decomposes upon strong heating, releasing acrid smoke and irritating fumes. Chemically, farnesol's functionality enables reactions such as esterification with carboxylic acids or oxoacids to form esters and . Its three carbon-carbon double bonds allow for to saturated analogs or acid-catalyzed between cis and trans configurations. Additionally, it reacts with strong oxidizing agents to produce oxidized derivatives and is incompatible with alkali metals, nitrides, or strong reducing agents, potentially generating flammable or toxic gases.

Natural Occurrence and Biosynthesis

Sources in Nature

Farnesol is a alcohol commonly found in the essential oils of various plants, where it contributes to their characteristic floral and fruity aromas as a volatile . Notable plant sources include the essential oils derived from (citronella), (rose), Citrus aurantium flowers (), Polianthes tuberosa (tuberose), and (Farnese acacia), the latter historically serving as an early commercial source that inspired the compound's name. In these essential oils, farnesol concentrations are typically low, ranging from 0.1% to 5%, though higher levels up to 2.5% have been reported in select species like cabreuva wood oil. In animals, farnesol occurs in trace amounts within human and mammalian tissues, primarily as an intermediate derived from (FPP), a key precursor in the mevalonate biosynthetic pathway. For instance, farnesol and its derivatives, including farnesal and farnesoic acid, have been detected in various mouse tissues such as liver, , and , highlighting its endogenous presence in vertebrates. These low-level occurrences underscore farnesol's role in cellular metabolism rather than as a major accumulated compound. Fungal and microbial sources also produce farnesol, particularly certain yeasts where it functions as a signaling . In Candida albicans, farnesol is secreted during growth, accumulating to regulate and . Similarly, Saccharomyces cerevisiae synthesizes farnesol, with production enhanced under alkaline conditions (pH 7.0–8.0), reaching measurable extracellular levels that influence cellular responses. These microbial productions align with farnesol's broader distribution via the , as detailed in biosynthetic studies.

Biosynthetic Pathways

Farnesol is primarily produced in living organisms through the hydrolysis of farnesyl pyrophosphate (FPP), a key intermediate in isoprenoid biosynthesis, catalyzed by specific phosphatases that cleave the pyrophosphate group. This reaction can be simplified as: \text{FPP} + \text{H}_2\text{O} \rightarrow \text{Farnesol} + \text{PPi} In eukaryotes such as animals, fungi, and the cytosolic compartment of plants, FPP is generated via the mevalonate (MVA) pathway. This pathway begins with the condensation of three molecules of acetyl-CoA to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA), which is reduced by HMG-CoA reductase to mevalonate. Mevalonate undergoes sequential phosphorylation and decarboxylation to yield isopentenyl pyrophosphate (IPP) and its isomer dimethylallyl pyrophosphate (DMAPP). These C5 units then condense: DMAPP reacts with IPP to form geranyl pyrophosphate (GPP, C10) via geranyl pyrophosphate synthase, followed by the addition of another IPP molecule to GPP, catalyzed by farnesyl diphosphate synthase (FPPS, EC 2.5.1.21), producing FPP (C15). FPPS is a critical enzyme that ensures the stereospecific formation of the all-trans configuration of FPP, and its activity is tightly regulated, particularly in pathways leading to cholesterol and steroid synthesis where FPP serves as a precursor for squalene production via squalene synthase. In many plants and bacteria, an alternative route known as the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway operates, primarily in plastids of plants and the cytoplasm of bacteria, to generate the same IPP and DMAPP precursors. This pathway starts with the condensation of pyruvate and to form 1-deoxy-D-xylulose 5-phosphate (DXP), which is rearranged and reduced to MEP. Subsequent cyclization, , and reduction steps, involving enzymes such as 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR) and (E)-4-hydroxy-3-methylbut-2-enyl reductase (IspH), yield IPP and DMAPP. From these building blocks, GPP and FPP are assembled identically to the MVA pathway via FPPS, ultimately leading to farnesol through phosphatase-mediated . The MEP pathway complements the MVA pathway in plants, allowing compartmentalized isoprenoid production, while in bacteria, it is the sole route for biosynthesis. The regulation of farnesol is interconnected with broader isoprenoid , where FPP levels influence downstream processes like and production in eukaryotes. For instance, excess FPP can feedback-inhibit early MVA pathway enzymes, such as , to maintain . In organisms relying on the MEP pathway, inhibitors like fosmidomycin target DXR to disrupt IPP/DMAPP supply, indirectly affecting farnesol formation. Specific , such as farnesyl diphosphate phosphatase (EC 3.1.7.6) in and microbial orthologs like those in , fine-tune farnesol release from FPP, ensuring balanced precursor availability for essential metabolites.

Commercial Production

Extraction from Natural Sources

Farnesol is primarily extracted from natural sources through physical separation techniques applied to plant materials rich in essential oils, such as those from citronella grass () and rose flowers (). Historically, early isolations occurred around 1900 from the flowers of , a shrub whose fragrant blooms provided the compound's namesake, yielding trace amounts of the sesquiterpene alcohol via initial solvent-based methods. These traditional approaches laid the foundation for commercial procurement, though modern extractions emphasize efficiency from higher-yielding plant matrices. Steam distillation remains a cornerstone method for obtaining farnesol-containing s, particularly from leaves and petals, where volatilizes the compounds, followed by and to collect the oil layer. This hydrodistillation process operates under mild conditions to preserve volatile components, with typical yields from petals ranging from 0.015% to 0.048% by weight of fresh material. extraction serves as an alternative or complementary technique, employing non-polar s like or polar ones like to dissolve and isolate farnesol from plant tissues, after which the solvent is evaporated and the extract fractionated by or precipitation to concentrate the target compound. These methods target the natural occurrence of farnesol in s, where it constitutes 0.5–1.0% of the total composition in most sources. Despite their efficacy for small-scale production, natural extraction processes suffer from low overall efficiency, with farnesol yields typically limited to trace amounts, often less than 0.01% relative to the input , rendering large-scale isolation uneconomical due to high labor and purification demands. Post-extraction purification is essential to isolate the predominant trans-trans , often involving to remove lower-boiling impurities under reduced pressure, minimizing thermal degradation, or chromatographic techniques like normal-phase for high-purity separation (up to 99%). These steps ensure the final product meets commercial standards for perfumery and other applications, though the inherent low concentration in source materials continues to favor synthetic alternatives for bulk .

Synthetic Methods

Farnesol is primarily produced commercially through a route starting from , involving to an ene-type intermediate followed by copper-catalyzed coupling. is treated with to generate the allylic via regioselective chlorination at the allylic . This then undergoes an SN2'-type with prenylmagnesium in the presence of a copper(I) , such as cuprous , yielding farnesol in good yields with high . This method leverages the abundance of from natural sources or synthesis, providing an efficient industrial pathway while allowing control over the double bond geometry. An alternative commercial approach involves the isomerization of , a constitutional of farnesol, under acidic conditions to directly afford the target . This simple rearrangement is favored in perfume industry production due to its high yield and the ready availability of nerolidol. The classical of farnesol proceeds via geranylacetone, prepared industrially from and acetone through base-catalyzed . Citral, an α,β-unsaturated , condenses with acetone to form the β,γ-unsaturated geranylacetone as a C13 intermediate in the terpene chain extension. Subsequent chain elongation occurs through a or, more commonly, the Horner-Wadsworth-Emmons (HWE) olefination using triethyl phosphonoacetate under basic conditions, introducing the terminal isoprenoid unit with E-selectivity. The resulting α,β-unsaturated ester is then reduced, typically with aluminum hydride, to yield farnesol after . This sequence emphasizes stereocontrol to produce the (E,E)-, the predominant form, with the HWE step achieving >90% E-geometry due to the stabilized character. For the HWE step, the reaction can be represented as: \ce{(CH3)2C=CH-CH2-CH2-C(CH3)=CH-(CH2)2-C(O)-CH3 + (EtO)2P(O)-CH2-CO2Et ->[NaH or NaOEt] (CH3)2C=CH-CH2-CH2-C(CH3)=CH-(CH2)2-C(CH3)=CH-CO2Et} followed by reduction: \ce{(CH3)2C=CH-CH2-CH2-C(CH3)=CH-(CH2)2-C(CH3)=CH-CO2Et ->[LiAlH4] (E,E)-farnesol} Modern synthetic methods incorporate biocatalysis with engineered enzymes for sustainable production. In metabolically engineered , the is optimized by overexpressing geranyl diphosphate (IspA) to form farnesyl diphosphate (FPP), coupled with phosphatases like PgpB or YbjG to hydrolyze FPP to farnesol, achieving extracellular titers of 1.08 g/L in fed-batch . Similarly, yeast strains such as have been modified with sesquiterpene s and phosphatase overexpression to co-produce farnesol alongside other terpenoids, reaching yields exceeding 6% of dry cell weight. These biocatalytic routes offer high specificity and reduced waste compared to traditional chemistry. Total synthesis from isoprene units builds the C15 skeleton through sequential assembly of C5 building blocks, often derived from isoprene via halogenation or phosphorylation. Seminal stereoselective approaches, such as those developed by Corey, employ modified Wittig-Schlosser reactions on β-hydroxy phosphonium salts to construct trisubstituted (E)-olefins iteratively, ensuring the (E,E)-configuration of farnesol with high purity (>95% stereoselectivity per step). This method highlights the emphasis on E,E-stereoselectivity across all routes, as the trans,trans-isomer predominates in natural sources and exhibits optimal biological activity, achieved through stabilized ylides or metal-mediated couplings that minimize Z-isomer formation.

Uses and Applications

In Perfumery and Cosmetics

Farnesol plays a significant role in , where it enhances floral notes such as lilac and lily-of-the-valley, imparting a delicate, fresh green-floral character often described as muguet-like. It functions as a to prolong the longevity of fragrance compositions and as a co-solvent to regulate the volatility of other odorants, allowing for better harmonization of notes. Typical usage levels in perfume compounds range from 0.5% to 5%, though maximum levels can reach up to 30% in specialized formulations. In cosmetics, farnesol serves as a deodorant agent by inhibiting the growth of odor-causing , thereby neutralizing without masking it. It is commonly incorporated into products like soaps, lotions, aftershaves, and at concentrations typically between 0.05% and 0.3% to provide effective activity while maintaining a subtle . Regulatory standards from the International Fragrance Association (IFRA) limit farnesol concentrations in finished products due to its potential to cause skin sensitization. For leave-on products such as body lotions and face moisturizers, the maximum acceptable level is 0.29%, while it is lower at 0.097% for baby creams and oils (as of IFRA Standards 49, 2022). Derivatives like farnesyl acetate are also employed in synthetic fragrances, adding volume and freshness to white flower accords with a subtle rosy, berry nuance.

In Pharmaceuticals and Research

Farnesol serves as a key intermediate in the , acting as a precursor for the synthesis of pharmaceuticals such as statins, which inhibit upstream of production to lower levels. It also contributes to the development of nitrogen-containing bisphosphonates, which target farnesyl diphosphate synthase to disrupt and treat conditions like and bone metastases. In anticancer , farnesol analogs form the basis of farnesyl inhibitors that block the of proteins, preventing oncogenic signaling in tumors. As an antibiotic adjuvant, farnesol enhances the efficacy of antimicrobial agents against biofilm-associated infections by inhibiting biofilm formation and promoting cell detachment in pathogens such as and . For instance, at concentrations around 3 mM, farnesol reduces C. albicans biofilm by over 50% when applied early in development and synergizes with drugs like to combat resistant , including . This adjuvant role extends to mixed-species biofilms, where farnesol disrupts and membrane integrity without direct bactericidal effects at low doses. In , farnesol is employed as a probe to study , where it replenishes farnesyl pools to reverse inhibition-induced effects like in models treated with statins or bisphosphonates. It induces in cancer cell lines by mechanisms including of diacylglycerol binding to and activation of pathways, independent of its effects on synthesis. These properties make it valuable for investigating cellular processes like arrest and geranylgeranylation in cardiovascular and proliferative diseases. Farnesol has shown potential in neurodegenerative therapy by promoting the farnesylation of the protein (ZNF746), which represses PGC-1α and contributes to mitochondrial dysfunction in models; supplementation with farnesol reduces PARIS accumulation and neurotoxicity in dopaminergic neurons. In , it disrupts signaling by modulating membrane localization and downstream pathways like ERK1/2, inhibiting tumor growth in and pancreatic models at doses that suppress proliferation without excessive toxicity. Derivatives such as farnesylthiosalicylic acid (Salirasib) further exemplify this by competing with farnesylated for chaperone binding, enhancing anti-tumor effects. Preclinical studies also indicate farnesol's potential in autoimmune conditions, such as reducing and disease severity in experimental autoimmune , a mouse model of , possibly by modulating gut and transcriptomics. Farnesol is additionally used as a flavoring agent in food products, where it imparts subtle floral notes and is recognized as (GRAS) by the U.S. (FDA) and evaluated as safe by the Joint FAO/WHO Expert Committee on Food Additives (JECFA). In pest control, it functions as an insect attractant, serving as a precursor to juvenile hormones and pheromones that influence reproductive behaviors, and as a repellent in formulations against and other pests. As of November 2025, farnesol is not approved as a standalone pharmaceutical but is incorporated into experimental formulations for treatments and therapies in preclinical and early-phase trials, including lipid systems to improve delivery against resistant infections. Ongoing investigations focus on its role in combination regimens for cancer and neurodegeneration, with no large-scale human trials reported for direct systemic use.

Biological Roles

In Microorganisms

In microorganisms, farnesol serves as a key quorum-sensing molecule, particularly in the fungal pathogen Candida albicans, where it accumulates at high cell densities to inhibit hyphal formation and biofilm development, thereby regulating morphogenesis and community behavior. This inhibition occurs through interference with the cAMP-protein kinase A signaling pathway, preventing the transition from yeast to hyphal forms essential for virulence and tissue invasion. Farnesol exhibits effects against various fungi by disrupting cell membranes, leading to leakage of intracellular contents and inhibition of growth. This membrane perturbation enhances the efficacy of agents, reducing in species like by downregulating efflux pumps and altering composition in the plasma membrane. Additionally, farnesol induces in under stress conditions, activating metacaspases and accumulation to eliminate damaged cells and control . In Candida albicans, this process involves externalization and DNA fragmentation, mimicking metazoan to maintain cellular . These biological effects are concentration-dependent, with farnesol effectively inducing morphological changes and inhibitory responses in at thresholds of 10–50 μM, corresponding to natural accumulation levels during stationary phase growth. At lower concentrations, it promotes adaptive responses, while higher levels trigger .

In Plants and Animals

In plants, farnesol serves as a volatile compound involved in signaling for defense mechanisms against herbivores and pathogens, contributing to the emission of herbivore-induced plant volatiles that attract enemies or deter attackers. As a derived from the of (FPP), it acts as a precursor in the of various sesquiterpenes found in oils, which enhance through and repellent properties. In , farnesol acts as a precursor to juvenile hormones, which regulate development, reproduction, and , and functions as a influencing reproductive behaviors and flagellar . In other animals, including vertebrates, farnesol functions as an intermediate in the , where two molecules of FPP are condensed to form , a key step in biosynthesis essential for membrane integrity and hormone production. It modulates calcium by inhibiting voltage-gated Ca²⁺ channels, potentially protecting against Ca²⁺-induced . Additionally, farnesol-derived FPP is crucial for the farnesylation of proteins, such as the small Ras and Rho, which regulates cellular signaling, proliferation, and cytoskeletal dynamics. In humans, endogenous farnesol is present at detectable levels in tissues like the skin, where it influences differentiation, and the liver, where it undergoes as part of its metabolism. It exhibits neuroprotective effects, particularly in models, by promoting the farnesylation of parkin-interacting substrate (PARIS, or ZNF746), which inhibits its repressive activity on PGC-1α and thereby prevents neurodegeneration. As of 2024, research also highlights farnesol's and properties, contributing to in broader neurodegenerative diseases. Metabolically, farnesol is primarily converted to through , enabling its role in and integration into broader . The physiological roles of farnesol reflect its evolutionary conservation, as the —responsible for its production—is ubiquitously present across eukaryotic kingdoms, originating early in evolution to support essential lipid modifications and signaling.

History and Nomenclature

Discovery

Farnesol was first isolated from the flowers of Vachellia farnesiana, known as the Farnese acacia, during the early 20th century. The compound was extracted via distillation of the acacia flowers and identified as a sesquiterpene alcohol, with the initial description appearing in scientific literature ca. 1900–1905. The structure, first proposed in 1898, was confirmed in the 1920s through degradation and synthesis by chemist Leopold Ruzicka, advancing understanding of sesquiterpenes in natural product chemistry.

Etymology

The name "farnesol" derives from (formerly Acacia farnesiana), known as the Farnese acacia, the plant from which the compound was first extracted in the early . The specific epithet farnesiana honors the prominent Italian Farnese family, particularly Cardinal Odoardo Farnese (1573–1626), whose botanical gardens in featured the first documented European cultivation of the plant around 1611, as described by Tobias Aldini in 1625. This connection reflects the family's patronage of under Cardinal Alessandro Farnese, linking the term to historical horticultural importations from the . The term "farnesol" itself was coined between 1900 and 1905, borrowing from German "farnesol" and appending the suffix "-ol" to denote its nature as an , in reference to its isolation from V. farnesiana flower extracts used in perfumery. Its earliest recorded use appears in 1904 in the Journal of the Chemical Society. Linguistically, it stems from the New Latin farnesiana, a Latinized form of the "Farnese" (from Latin Farnesianus), emphasizing the botanical over a purely systematic chemical descriptor. To distinguish isomers, terms like "trans,trans-farnesol" or "(E,E)-farnesol" specify the configuration of the molecule's double bonds, reflecting its sesquiterpenoid structure. In the mid-20th century, the International Union of Pure and Applied Chemistry (IUPAC) adopted the systematic name (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol for the predominant all-trans , standardizing for precision in and avoiding ambiguity in terpenoid chemistry.

References

  1. [1]
    Farnesol
    Summary of each segment:
  2. [2]
    trans-Farnesol - the NIST WebBook
    trans-Farnesol has the formula C15H26O, molecular weight 222.3663, CAS number 106-28-5, and is also known as all-trans-Farnesol.Missing: roles | Show results with:roles<|control11|><|separator|>
  3. [3]
    Mode of Action of Farnesol, the “Noble Unknown” in Particular in ...
    Farnesol does not have the status of a hormone in vertebrates, neither of a control agent of Ca2+-homeostasis, but is only known as an intermediate in the ...
  4. [4]
    Chemistry and Biology of Farnesol and its Derivatives - PubMed
    Farnesol is a quorum sensing molecule involved in inhibiting hyphae formation, and has anti-biofilm, anti-cancer, and antimicrobial properties. It can also be  ...Missing: roles | Show results with:roles
  5. [5]
  6. [6]
    Biological effects of trans, trans-farnesol in Leishmania amazonensis
    Candida albicans predominantly secretes the trans, trans-farnesol (t, t-FOH) isomer, known for its role in regulating the virulence of various fungi species ...
  7. [7]
    FARNESOL | 4602-84-0
    ### Summary of Farnesol Physical and Chemical Properties
  8. [8]
  9. [9]
    FARNESOL - CAMEO Chemicals - NOAA
    Physical Properties. What is this information? The Physical Property fields include properties such as vapor pressure and boiling point, as well as explosive ...Missing: appearance refractive index stability
  10. [10]
    CN108026006A - The production of farnesol - Google Patents
    By acid isomerization come synthetically produced farnesol.Huge shortcoming ... The reaction of step (2) can also be transfer hydrogenation.This ...
  11. [11]
    Synthesis of Farnesol Isomers via a Modified Wittig Procedure
    The four olefin stereoisomers of farnesol have been synthesized from readily available nerylacetone or commercial geranylacetone. A new variation on the use ...
  12. [12]
    Toxicological and pharmacologic effects of farnesol (C15H26O)
    The name Farnesol was given for being first identified in Vachellia farnesiana (L.) Wight & Arn flowers, known as “acacia farnese”, the “ol” suffix was added ...
  13. [13]
    Phytochemistry and Biological Activities of Essential Oils from Six ...
    The main volatile compounds in the EO from the flowers of Citrus aurantium are linalool (29.01%), (2E,6E)-farnesol ... Oils that have high percentages of ...
  14. [14]
    Farnesol-Like Endogenous Sesquiterpenoids in Vertebrates - NIH
    Occurrence of farnesol, its precursor farnesyl pyrophosphate (FPP) and its derivatives, farnesal and farnesoic acid in a variety of tissues of a male mouse ...
  15. [15]
    Modulation of Neuronal Voltage-gated Calcium Channels by Farnesol
    Farnesol Is Naturally Occurring in Brain Tissue. One of the enzymes required for the production of farnesol (farnesyl-pyrophosphate synthase) is known to be ...
  16. [16]
    Farnesol Biosynthesis in Candida albicans: Cellular Response to ...
    The dimorphic fungus Candida albicans produces farnesol as a quorum-sensing molecule that regulates cellular morphology. The biosynthetic origin of farnesol ...
  17. [17]
    Alkaline pH enhances farnesol production by Saccharomyces ...
    Cultivation of the yeast in medium with an initial pH ranging from 7.0 to 8.0 increased the amount of secreted farnesol (FOH).
  18. [18]
    Quorum Sensing in Dimorphic Fungi: Farnesol and Beyond - PMC
    Production of farnesol by Candida albicans is the first quorum-sensing system discovered in a eukaryote (29). In C. albicans, accumulated farnesol affects ...
  19. [19]
    Mode of Action of Farnesol, the “Noble Unknown” in ... - Frontiers
    Farnesol has been shown to be a potent endogenous inhibitor of N-type voltage-gated Ca 2+ channels in some mammalian cell types.<|control11|><|separator|>
  20. [20]
    Essential Oil Extracted from Cymbopogon citronella Leaves by ...
    Jan 2, 2019 · The highest essential oil yield was predicted at extraction time 120 min, extraction pressure 25 MPa, extraction temperature 35°C, and CO2 flow ...
  21. [21]
    Comparative Study of the Yield and Chemical Profile of Rose Oils ...
    Jul 10, 2023 · Our study showed that the yield of essential oil from these roses was in the range of 0.015–0.048%. The main group in the chemical composition ...
  22. [22]
    A Comprehensive Guide to Essential Oil Extraction Methods
    Mar 20, 2017 · SOLVENT EXTRACTION​​ This method employs food grade solvents like hexane and ethanol to isolate essential oils from plant material.Missing: farnesol | Show results with:farnesol
  23. [23]
    Microbial production of farnesol (FOH): Current states and beyond
    This review is focused on recent progress on cellular metabolism involved in FOH biosynthesis and FOH production from microorganisms.Missing: concentration | Show results with:concentration
  24. [24]
    [PDF] Extraction of Sandalwood Essential Oil: Isolating α/β-Santalol
    Krugelrohr vacuum distillation effectively pre- purified oil by isolation of fragrant compounds. Flash column chromatography afforded a predominantly ...
  25. [25]
    Recovery of E,E-farnesol from cultures of yeast erg9 mutants - PubMed
    The solvent-free crude extract from the beads extraction contained higher concentration of farnesol (76-77%) than that from the solvent extraction (61-65%).
  26. [26]
    Synthesis of Sesquiterpene Alcohols such as Nerolidol ... - J-Stage
    The ene-type chlorination of terpenyl alcohols such as linalool (1 a), geraniol (1 b), nerol (1 c) and citronellol (1 d) with hypochlorous acid gave allylic ...
  27. [27]
    Farnesol (CAS N° 4602-84-0) - ScenTree
    The smell of Farnesol becomes stronger when the molecule is evaporating, surely due to oxydation. Farnesol is part of the sesquiterpene molecule category. This ...Missing: solubility reactivity
  28. [28]
    Process for the Preparation of (3E, 7E)-Homofarnesol - Google Patents
    The C 13 building block geranyl acetone is available industrially and cost-effectively as intermediate from the citral value-addition chain. The desired (E)- ...
  29. [29]
  30. [30]
    Farnesol production in Escherichia coli through the construction of a ...
    Jul 21, 2016 · By enhancing the FPP synthesis, farnesol of 145.7 mg/L has been produced in Saccharomyces cerevisiae via a long-time (seven days) fermentation ...
  31. [31]
    [PDF] Yeast Metabolic Engineering for Production of Farnesol and ...
    ❖ Farnesol was efficiently released from the cells as soon as it was produced. ❖ Dry cell weight reached approximately 44 g/L. Total farnesol level exceeded 6% ...
  32. [32]
    Journal of the American Chemical Society
    New stereospecific synthesis of trisubstituted olefins. Stereospecific synthesis of farnesol. Click to copy article linkArticle link copied! Elias J. Corey ...
  33. [33]
    farnesol, 4602-84-0 - The Good Scents Company
    Refractive Index: 1.48700 to 1.49200 @ 20.00 °C. Boiling Point: 149.00 °C. @ 4.00 mm Hg. Boiling Point: 263.00 °C. @ 760.00 mm Hg. Vapor Pressure: 0.000370 ...Missing: reactivity | Show results with:reactivity
  34. [34]
    Farnesol - PerfumersWorld
    Farnesol is a delicate, fresh green floral. It has a clean muguet and linalool quality. It has a sweet-oily odor that develops slowly.Missing: fixative | Show results with:fixative
  35. [35]
    Farnesol - Cosmetics Info
    In cosmetics and personal care products, Farnesol is used in the formulation of aftershave lotions, cleansing products, colognes, deodorants, eye lotions, face ...
  36. [36]
  37. [37]
    Farnesol Deodorant Ingredient for Effective Odour Control
    14-day returnsA: The full ingredient is Farnesol as shown in the INCI in the product description, this is a cosmetic ingredient for external use of 0.5% as part of a ...
  38. [38]
    FARNESOL – Ingredient - COSMILE Europe
    The average content of fragrances amounts in perfume to 15-30 %, in eau de parfum to 10-14 %, in eau de toilette to 6-9 %, in eau de cologne to 3-5 % as well ...
  39. [39]
    [PDF] RIFM fragrance ingredient safety assessment, farnesol, CAS ...
    Nov 25, 2023 · Human peripheral blood lymphocytes were treated with farnesol in DMSO at concentrations up to 2270 μg/mL in the dose range finding study; the ...
  40. [40]
    farnesyl acetate, 29548-30-9 - The Good Scents Company
    Farnesyl acetate, also known as 3,7,11-trimethyldodeca-2,6,10-trienyl acetate, is used for rose compositions and has a subtle rosiness with raspberry and berry ...
  41. [41]
    Farnesyl acetate (CAS N° 29548-30-9) - ScenTree
    Farnesyl acetate, also known as Farnesol acetate, is a colorless liquid used to add volume and freshness in white flower accords. It is made by esterification ...
  42. [42]
    Fragrance material review on farnesol - ScienceDirect.com
    Its use worldwide is in the region 1–10 metric tonnes per annum. The maximum skin level that results from the use of farnesol in formulae that go into fine ...
  43. [43]
    Regulation of protein prenylation - ScienceDirect
    Another drug class interfering with the MVA pathway is nitrogen-containing bisphosphonates (N-BPs), inhibitors of farnesyl diphosphate synthase (FDPS). They are ...
  44. [44]
    Lipid Posttranslational Modifications. Fighting parasitic disease by ...
    This review will discuss the current efforts and progress in developing inhibitors of protein farnesyltransferase (PFTIs) as antiparasitic agents. PROTEIN ...
  45. [45]
    Effects of tyrosol and farnesol on Candida albicans biofilm - PubMed
    Feb 22, 2019 · Farnesol at 3 mM exerted a stronger action when added at the beginning of biofilm formation (>50% inhibition) than when added to preformed ...
  46. [46]
    Farnesol repurposing for prevention and treatment of Acinetobacter ...
    Since farnesol was first found to inhibit filamentation and biofilm formation of the fungus Candida albicans in 2002 [16], it has shown versatile functions ...
  47. [47]
    Farnesol induces cell detachment from established S. epidermidis ...
    We recently described a bacterial strain where farnesol had no detectable antibiotic effect but strongly reduced biofilm biomass. We hypothesized that ...
  48. [48]
    Depletion of substrates for protein prenylation increases apoptosis ...
    The increase in apoptosis caused by simvastatin or Org 31710 was partially reversed by addition of the protein prenylation precursors farnesol or ...
  49. [49]
    Molecular mechanisms involved in farnesol-induced apoptosis
    The isoprenoid alcohol farnesol is an effective inducer of cell cycle arrest and apoptosis in a variety of carcinoma cell types. In addition, farnesol has ...
  50. [50]
    Research advances in protein prenylation in cardiovascular diseases
    Oct 15, 2025 · Prenylation modulates cellular processes—including proliferation, apoptosis, oxidative stress, and metabolism—through structural and functional ...
  51. [51]
    PARIS farnesylation prevents neurodegeneration in models of ...
    Jul 28, 2021 · Farnesol promoted the farnesylation of PARIS, preventing its repression of PGC-1α via decreasing PARIS occupancy on the PPARGC1A promoter.
  52. [52]
  53. [53]
    The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the ...
    The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer. Methods ...
  54. [54]
  55. [55]
  56. [56]
    Inhibition of Candida albicans biofilm formation by farnesol, a ...
    Farnesol is a quorum-sensing molecule that inhibits filamentation in Candida albicans. Both filamentation and quorum sensing are deemed to be important factors.
  57. [57]
    Quorum sensing controls hyphal initiation in Candida albicans ...
    Here, we show that farnesol controls hyphal initiation through the N-end rule pathway-mediated protein degradation.
  58. [58]
    Effect of Farnesol in Trichoderma Physiology and in Fungal–Plant ...
    Farnesol is an isoprenoid intermediate in the mevalonate (MVA) pathway and is produced by the dephosphorylation of farnesyl diphosphate.<|control11|><|separator|>
  59. [59]
    Antimicrobial effect of farnesol, a Candida albicans quorum sensing ...
    Apr 29, 2009 · Studies revealed that farnesol affect the growth of a number of bacteria and fungi, pointing to a potential role as an antimicrobial agent.
  60. [60]
    The possible molecular mechanisms of farnesol on the antifungal ...
    Dec 4, 2018 · Farnesol suppresses the resistance of C. albicans biofilms to antifungals by regulating the expression of the gene CYR1 and PDE2.<|control11|><|separator|>
  61. [61]
    Farnesol-Induced Apoptosis in Candida albicans - ASM Journals
    ... farnesol exposure results in immediate disruption of the cell membrane, leading to necrosis. In contrast, in other cells the process of farnesol toxicity ...
  62. [62]
    Farnesol-Induced Apoptosis in Candida albicans Is Mediated by ...
    This is the first study describing the involvement of Cdr1p-mediated glutathione efflux as a mechanism preceding the farnesol-induced apoptotic process in C. ...
  63. [63]
    Effects of tyrosol and farnesol on Candida albicans biofilm
    Feb 22, 2019 · The present in vitro study examined the effects of the quorum‑sensing molecules farnesol and tyrosol on the development of Candida albicans ...
  64. [64]
    In vitro and in vivo Effect of Exogenous Farnesol Exposure Against ...
    May 19, 2020 · Interestingly, the low farnesol concentrations (10–50 μM) increased the metabolic activity of C. albicans biofilms in the first 4 h (Figure ...
  65. [65]
    Effect of Farnesol in Trichoderma Physiology and in Fungal–Plant ...
    The highest farnesol concentration induced the up-regulation of the plant defense-related genes PR1b1 and PR-P2, which belong to the salicylic signaling ...
  66. [66]
    Essential Oils as Natural Sources of Fragrance Compounds for ...
    In nature, essential oils play very important roles in plant defense and signaling processes. ... farnesol, sesquiterpenes, methyl heptenone, esters, acids and ...
  67. [67]
    Plant-Derived Terpenoids: A Plethora of Bioactive Compounds with ...
    Farnesyl pyrophosphate (FPP) is the precursor to sesquiterpenes. It can hydrolyze farnesol or rearrange nerodyl pyrophosphate, which is the substrate of ...
  68. [68]
    Synthesis, function, and regulation of sterol and nonsterol isoprenoids
    Oct 5, 2022 · Two FPP molecules are condensed to form squalene by squalene synthase (also called farnesyl diphosphate farnesyltransferase 1, FDFT1).
  69. [69]
    The Biomedical Importance of the Missing Pathway for Farnesol and ...
    Dec 8, 2022 · This review presents, in a simplified but comprehensive manner, the most important data on the FOH and GGOH salvage pathway, stressing its biomedical ...
  70. [70]
    Isoprenoids and Protein Prenylation: Implications in the ...
    Two major isoprenoids, farnesyl and geranylgeranyl pyrophosphate, are required to modify an array of proteins through a process known as protein prenylation.Isoprenoid Synthesis · Protein Prenylation · Biochemical Evidence
  71. [71]
    Farnesol Stimulates Differentiation in Epidermal Keratinocytes via ...
    Our experiments with deletional INV constructs revealed a region of the INV promoter (−2452 bp to −1880 bp) that was responsive to farnesol and JH.
  72. [72]
    Molecular Mechanisms involved in Farnesol-Induced Apoptosis - NIH
    This review provides an overview ... Farnesol inhibits phosphatidylcholine biosynthesis in cultured cells by decreasing cholinephosphotransferase activity.
  73. [73]
    PARIS farnesylation prevents neurodegeneration in models of ...
    Thus, farnesol may be beneficial in the treatment of PD by enhancing the farnesylation of PARIS and restoring PGC-1α activity. INTRODUCTION. Parkinson's disease ...
  74. [74]
    Calcitox-aging counterbalanced by endogenous farnesol-like ...
    In endocrine studies on the mode of action of juvenile hormone, farnesol and some GPCRs, little attention is given to the importance of prenylation. Yet, it may ...
  75. [75]
    Chance long-distance or human-mediated dispersal? How Acacia ...
    Apr 12, 2017 · How A. farnesiana arrived in Australia remains a historical enigma. It may be that a single chance event of oceanic dispersal [68] brought the ...Missing: farnesol | Show results with:farnesol
  76. [76]
    FARNESOL Definition & Meaning - Dictionary.com
    The inner core reacts to high acidity in the mouth, which loosens up the nanospheres and preferentially releases their contents—the antibacterial drug farnesol ...Missing: etymology | Show results with:etymology
  77. [77]
    farnesol, n. meanings, etymology and more - Oxford English Dictionary
    OED's earliest evidence for farnesol is from 1904, in Journal of Chemical Society. farnesol is a borrowing from German. Etymons: German farnesol. See etymology ...
  78. [78]
    FARNESOL definition in American English - Collins Dictionary
    Word origin. C20: from New Latin (Acacia) farnesiāna; named after Odoardo Farnese, C17 Italian cardinal. Quick word challenge. Quiz Review. Question: 1. -.Missing: etymology | Show results with:etymology